Skip to main content

Braslyn Ltd.

SEC CIK
0001642355
Latest filing
Feb 14, 2025

MRTX holding history

Mirati Therapeutics, Inc. in every 13F filed by Braslyn Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MRTX overviewAll 13F holders of MRTXFull Q4 2024 holdings

Shares (Q1 2024)
0
Sold out in Q1 2024
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q4 2023
Holdings of MRTX by Braslyn Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20240$00.0%−3,135,966−100.0%Sold outHolders
Q4 20233,135,966$184.2M99.0%–No prior filingHolders